|
MechanismMTHFD1L inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismMTHFD2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with One-Carbon Therapeutics AB
0 Patents (Medical) associated with One-Carbon Therapeutics AB
100 Deals associated with One-Carbon Therapeutics AB
100 Translational Medicine associated with One-Carbon Therapeutics AB